Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Composition for reducing uric acid and application thereof

A composition and uric acid-lowering technology, which can be used in drug combinations, medical preparations containing active ingredients, applications, etc., can solve the problem of long removal period and achieve the effect of no toxic side effects

Active Publication Date: 2015-12-09
北京知蜂堂健康科技股份有限公司
View PDF9 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, it takes a long time to achieve normal blood uric acid level and the removal of vent stones. After 3 months of consumption, the total effective rate can only reach 96.1%.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Composition for reducing uric acid and application thereof
  • Composition for reducing uric acid and application thereof
  • Composition for reducing uric acid and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] Embodiment 1: A kind of composition of reducing uric acid

[0035] (1) Preparation of composition tablet

[0036] Formula: marine fish oligopeptide powder 25wt%, moringa leaf powder 20wt%, acerola cherry concentrate 10wt%, greengage extract 15wt%, edible accessories 30wt%.

[0037] Tablet preparation: Weigh the raw materials according to the above formula, mix them uniformly, and make 0.6g / tablets.

[0038] (2) Efficacy verification test

[0039] Patient data: 198 patients, including 120 males, aged 39-77 years old; 78 females, aged 53-74 years old.

[0040] Diagnostic criteria: the patient has arthralgia, nocturnal onset, difficulty in falling asleep; increased blood uric acid, higher than 6.0 mg / dL for males and higher than 5.0 mg / dL for females; tophi.

[0041] How to take it: 2 times a day, 2 tablets each time, once in the morning and evening, for 2 consecutive months.

[0042] Efficacy evaluation criteria: cure: laboratory test blood uric acid value is normal, ...

Embodiment 2

[0047] Embodiment 2: A kind of composition of reducing uric acid

[0048] (1) Preparation of composition powder

[0049] Formula: marine fish oligopeptide powder 10wt%, moringa leaf powder 10wt%, acerola cherry concentrate 8wt%, greengage extract 10wt%, edible accessories 62wt%.

[0050] Powder preparation: weigh the raw materials according to the above formula, mix them evenly, and make 2g / bag of powder.

[0051] (2) Efficacy verification test

[0052] Patient data: 173 patients, including 106 males, aged 42-73 years old; 67 females, aged 50-71 years old.

[0053] Diagnostic criteria: the patient has arthralgia, nocturnal onset, difficulty in falling asleep; increased blood uric acid, higher than 6.0 mg / dL for males and higher than 5.0 mg / dL for females; tophi.

[0054] Instructions: 2 times a day, 1 bag each time, once in the morning and evening, for 2 consecutive months.

[0055] Efficacy evaluation criteria: cure: laboratory test blood uric acid value is normal, joint ...

Embodiment 3

[0061] Embodiment 3: A kind of composition of reducing uric acid

[0062] (1) Preparation of composition hard capsules

[0063] Formula: marine fish oligopeptide powder 30wt%, moringa leaf powder 15wt%, acerola cherry concentrate 10wt%, greengage extract 10wt%, edible accessories 35wt%.

[0064] Preparation of hard capsules: take the raw materials according to the above formula, mix them uniformly, and make 0.5g / grain hard capsules.

[0065] (2) Efficacy verification test

[0066] Patient data: 181 patients, including 101 males, aged 40-69 years old; 80 females, aged 51-73 years old.

[0067] Diagnostic criteria: the patient has arthralgia, nocturnal onset, difficulty in falling asleep; increased blood uric acid, higher than 6.0 mg / dL for males and higher than 5.0 mg / dL for females; tophi.

[0068] Instructions: 2 times a day, 2 capsules each time, once in the morning and evening, for 2 consecutive months.

[0069] Efficacy evaluation criteria: cure: laboratory test blood ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a composition for reducing uric acid and application thereof. Ocean fish oligopeptide powder, moringa oleifera leaf powder, acerola cherry concentrates and green plum extract are used as raw materials and matched with various edible auxiliary materials to prepare the composition. The composition is prepared from, by weight, 5-35% of ocean fish oligopeptide powder, 5-45% of moringa oleifera leaf powder, 2-15% of acerola cherry concentrates, 5-30% of green plum extract and the balance edible auxiliary materials. The food raw materials are selected and synergistically take effects by means of scientific compatibility, so that the composition is high in uric acid reducing speed, remarkable in effect, safe and free from side effects.

Description

technical field [0001] The invention belongs to the field of health food, and in particular relates to a composition for reducing uric acid and its application, in particular to a composition of food for reducing uric acid and a new resource food and the application thereof. Background technique [0002] A normal adult produces about 750 mg of uric acid per day, of which 80% is endogenous and 20% is exogenous uric acid. These uric acids enter the uric acid metabolic pool (about 1200 mg), and about 60% of the uric acid in the daily metabolic pool is metabolized. Among them, about 1 / 3 of about 200 mg is catabolized by the intestinal tract, and 2 / 3 of about 400 mg is excreted by the kidneys, so as to maintain the stability of the uric acid level in the body. Increased uric acid production or decreased uric acid excretion caused by purine metabolism disorders can lead to hyperuricemia. Modern medicine has made it clear that the onset of gout is directly related to hyperuricemia...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/05A61K38/06A61K38/07A61K38/08A61P19/06A23L1/29A61K36/736A61K35/60A23L33/00
Inventor 李育强黄翼东宋贵林杨阿静
Owner 北京知蜂堂健康科技股份有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com